Viewing Study NCT06145360


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2025-12-27 @ 10:58 PM
Study NCT ID: NCT06145360
Status: COMPLETED
Last Update Posted: 2024-04-08
First Post: 2023-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient
Sponsor: SINA Health Education and Welfare Trust
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module